Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis

Published:2024-12 Issue: Volume:167 Page:209511
ISSN:2949-8759
Container-title:Journal of Substance Use and Addiction Treatment
language:en
Short-container-title:Journal of Substance Use and Addiction Treatment

Author:

Chan Brian,Cook Ryan,Levander Ximena,Wiest Katharina,Hoffman Kim,Pertl Kellie,Petluri Ritwika,McCarty Dennis,Korthuis P. Todd,Martin Stephen A.

Funder

National Institutes of Health

Agency for Healthcare Research and Quality

National Institute on Drug Abuse

Publisher

Elsevier BV

Reference39 articles.

1. Tier-based treatment for opioid use disorder in the primary care setting;Angier;Families, Systems & Health,2021

2. Integrating opioid use disorder treatment into primary care settings;Austin;JAMA Network Open,2023

3. Patient evaluation of a smartphone application for telehealth care of opioid use disorder;Bosse;Addiction Science & Clinical Practice,2022

4. Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS;Boyett;Drug and Alcohol Dependence,2021

5. Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects;Buchheit;Journal of Substance Abuse Treatment,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP